Ontx stock forecast zacks
WebFind the latest Onconova Therapeutics, Inc. ONTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date … WebBased on our forecasts, a long-term increase is expected, the "TNXP" stock price prognosis for 2028-02-16 is 0.860 USD. With a 5-year investment, the revenue is expected to be around +36.26%. Your current $100 investment may be up to $136.26 in 2028. Get our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee!
Ontx stock forecast zacks
Did you know?
WebHá 2 dias · Zacks' proprietary data indicates that Onconova Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the ONTX shares … WebONTX Stock 12 Months Forecast $6.00 (669.23% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Onconova Therapeutics in the last 3 months. The …
WebFind the latest Onconova Therapeutics, Inc. ONTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating... Web15 de out. de 2024 · About the BioNTech SE stock forecast. As of 2024 April 13, Thursday current price of BNTX stock is 127.760$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. BioNTech SE - ADR stock price has been showing a declining tendency so we believe that similar market segments …
WebOnconova Therapeutics, Inc. (ONTX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 (-0.30%) Onconova Therapeutics, Inc. (ONTX) NasdaqCM - NasdaqCM Real … WebOn average, Wall Street analysts predict that Cidara Therapeutics 's share price could reach $5.50 by Mar 24, 2024. The average Cidara Therapeutics stock price prediction …
WebFind real-time SB - Safe Bulkers Inc stock quotes, company profile, ... EPS forecast (this quarter) $0.14: Annual revenue (last year) $349.7M: Annual profit (last year) $172.6M:
WebOnconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? diamond gauges earringsWebSNDL Sales Forecast. Next quarter’s sales forecast for SNDL is $174.20M with a range of $168.78M to $180.95M. The previous quarter’s sales results were $176.47M. SNDL beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 51.63% of the time in the same period. circular readiness levelWeb12 de ago. de 2024 · Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.28. This … circular ratchet mechanismWebONTX: Onconova Therapeutics - Brokerage Reports - Zacks.com Onconova Therapeutics (ONTX) (Delayed Data from NSDQ) $0.80 USD +0.02 (1.91%) Updated Mar 17, 2024 … circular reactions psychologyWebFind real-time ONTX - Onconova Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.30: Annual revenue (last year) diamond gauntlets of strikingWeb10 de abr. de 2024 · Onconova Therapeutics - ONTX - Stock Price Today - Zacks Onconova Therapeutics (ONTX) (Delayed Data from NSDQ) $0.69 USD -0.11 (-13.75%) Updated Mar 20, 2024 04:00 PM ET After-Market:... In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, … diamond g bar cWeb13 de abr. de 2024 · 5 analysts have issued 12-month target prices for Ocugen's shares. Their OCGN share price forecasts range from $3.00 to $8.00. On average, they expect the company's stock price to reach $4.80 in the next year. This suggests a possible upside of 512.6% from the stock's current price. View analysts price targets for OCGN or view top … circular ray ban glasses